This record was last updated April 6, 2026 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This study will examine the safety of three times weekly SC injections of OPT101 at each of three dose levels over two weeks as well as one year of treatment with SC OPT101 or placebo to match at a single dose level.
Protocol Amendment History
2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-04-30; most recent amendment 2026-04-02.
Status change: Active, Not Recruiting → Recruiting2026-04-02
Status change: Not Yet Recruiting → Active, Not Recruiting2025-09-09